Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody persistence in pre-school children after hexavalent vaccine infant primary and booster administration
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2018-12-05
DOI
10.1080/21645515.2018.1546524
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Persistence of hepatitis B immune memory until 9–10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months
- (2018) Pope Kosalaraksa et al. Human Vaccines & Immunotherapeutics
- A Randomized, Controlled Study of DTaP-IPV-HB-PRP-T, a Fully Liquid Hexavalent Vaccine, Administered in a 3-, 5- and 11- to 12-month Schedule
- (2017) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A Randomized Controlled Study of a Fully Liquid DTaP-IPV-HB-PRP-T Hexavalent Vaccine for Primary and Booster Vaccinations of Healthy Infants and Toddlers in Latin America
- (2017) Pío López et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A fully liquid DTaP-IPV-HB-PRP-T hexavalent vaccine for primaryand booster vaccination of healthy Turkish infants and toddlers*
- (2017) Mehmet CEYHAN et al. Turkish Journal Of Medical Sciences
- Concomitant administration of a fully liquid, ready-to-use DTaP-IPV-HB-PRP-T hexavalent vaccine with a meningococcal serogroup C conjugate vaccine in infants
- (2017) Timo Vesikari et al. VACCINE
- Immunogenicity and safety of a liquid hexavalent vaccine in Indian infants
- (2016) Jugesh Chhatwal et al. INDIAN PEDIATRICS
- Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine
- (2016) Olivier Van Der Meeren et al. VACCINE
- Immune memory to hepatitis B persists in children aged 7–8 years, who were vaccinated in infancy with 4 doses of hexavalent DTPa-HBV-IPV/Hib (Infanrix™ hexa) vaccine
- (2014) Olivier Van Der Meeren et al. Human Vaccines & Immunotherapeutics
- Review of a new fully liquid, hexavalent vaccine: Hexaxim
- (2013) Marta C Nunes et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Antibody Persistence and Booster Vaccination of a Fully Liquid Hexavalent Vaccine Co-Administered with Measles/Mumps/Rubella and Varicella Vaccines at 15-18 Months of Age in Healthy South African Infants
- (2013) Shabir A. Madhi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®)
- (2013) Paul L. McCormack PEDIATRIC DRUGS
- Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzaetype b vaccine; Infanrix™ hexa
- (2013) Vincenzo Baldo et al. Human Vaccines & Immunotherapeutics
- Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response
- (2013) Yong Poovorawan et al. Human Vaccines & Immunotherapeutics
- Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America
- (2012) Mercedes Macías et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children
- (2012) Amalia Guadalupe Becerra Aquino et al. VACCINE
- Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin America
- (2012) Eduardo Santos-Lima et al. VACCINE
- Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers
- (2012) Yong Poovorawan et al. Human Vaccines & Immunotherapeutics
- A DTaP–IPV//PRP∼T vaccine (Pentaxim™): a review of 16 years’ clinical experience
- (2011) Stanley A Plotkin et al. Expert Review of Vaccines
- Immunogenicity of a two-component (PT&FHA) acellular pertussis vaccine in various combinations
- (2011) Emmanuel Vidor et al. Human vaccines & immunotherapeutics
- Immunogenicity and safety study of a new DTaP–IPV–Hep B–PRP-T combined vaccine compared to a licensed DTaP–IPV–Hep B//PRP-T comparator, both concomitantly administered with a 7-valent pneumococcal conjugate vaccine at 2, 4, and 6 months of age in Thai infants
- (2011) Pope Kosalaraksa et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of an Investigational Hexavalent Diphtheria-tetanus-acellular Pertussis-inactivated Poliovirus-hepatitis B-Haemophilus influenzae B Conjugate Combined Vaccine in Healthy 2-, 4-, and 6-month-old Argentinean Infants
- (2011) Miguel W. Tregnaghi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Immunogenicity and Safety of an Investigational Fully Liquid Hexavalent Combination Vaccine Versus Licensed Combination Vaccines at 6, 10, and 14 Weeks of Age in Healthy South African Infants
- (2011) Shabir A. Madhi et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa™)
- (2010) Sohita Dhillon DRUGS
- Immunogenicity and safety of a novel yeast Hansenula polymorpha-derived recombinant Hepatitis B candidate vaccine in healthy adolescents and adults aged 10–45 years
- (2010) Miguel W. Tregnaghi et al. VACCINE
- Review of 8 years of experience with Infanrix hexa™ (DTPa–HBV–IPV/Hib hexavalent vaccine)
- (2009) Fred Zepp et al. Expert Review of Vaccines
- Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand
- (2009) Yong Poovorawan et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now